Hormone Receptor Negative Tumor clinical trials at UCSF
1 research study open to eligible people
A hormone receptor negative tumor does not grow in response to hormones. UCSF is conducting trials to study new treatments for these types of breast cancer. These trials focus on personalized medicine to find the best drugs for each patient.
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
open to eligible people ages 18 years and up
The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.
San Francisco, California and other locations
Last updated: